CMBA
CNMD icon

C.M. Bidwell & Associates’s CONMED CNMD Stock Holding History

C.M. Bidwell & Associates’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,810
Closed -$202K – 372
2019
Q4 		$202K Sell
1,810
-125
-6% -$13.3K 0.18% 120
2019
Q3 		$186K Sell
1,935
-175
-8% -$16.4K 0.18% 136
2019
Q2 		$181K Sell
2,110
-160
-7% -$13.2K 0.18% 130
2019
Q1 		$189K Buy
+2,270
New +$165K 0.19% 133

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

C.M. Bidwell & Associates's CNMD Position: Q1 2020 in Review

C.M. Bidwell & Associates sold out of CONMED (CNMD) in Q1 2020, closing a stake of 1,810 shares — an estimated $202K sold.

C.M. Bidwell & Associates first reported a position in CNMD in Q1 2019 and held it in 4 quarters. The position peaked at $202K in Q4 2019. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • C.M. Bidwell & Associates reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,810 CONMED shares in Q1 2020, an estimated $202K.
  • C.M. Bidwell & Associates first reported a position in CONMED in Q1 2019 and held it in 4 quarters.
  • C.M. Bidwell & Associates's CONMED position peaked at $202K in Q4 2019.
  • 228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2020, filed 15 May 2020.